Brief: Adocia Says Sanofi’S Exclusive Right For Partnership Agreement For Development Of M1Pram Has Expired
BRIEF-Adocia Says Sanofi’S Exclusive Right For Partnership Agreement For Development Of M1Pram Has Expired July 3 (Reuters) - Adocia SA ADOC.PA:
ANNOUNCES EXPIRY OF SANOFI’S EXCLUSIVE RIGHT TO NEGOTIATE A PARTNERSHIP AGREEMENT FOR THE DEVELOPMENT OF M1PRAM
Source text: [ID:]
Further company coverage: ADOC.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Sanofi SA
See all newsEdenTree fund manager Hiorns has bought up French stocks despite civil unrest (updated)
Early US flu season, current strain may signal risk for younger people; doctors urge shots
Brief: Sanofi Starts Work On Insulin Facility In Germany
RCS - Accession Theraptcs. - Accession Therapeutics: Board appointments
Europe Research Roundup: AJ Bell, CMC Markets, Nestle